Guangyu Y. An
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 99 publications
Advanced Lung Cancer Inflammation Index as a Prognostic Inflammation-Nutrition Marker in Appendiceal High-Grade Pseudomyxoma Peritonei: A 10-Year Single-Center Study.
Journal: ANZ journal of surgery
Published: May 13, 2026
Derivation and external validation of a prognostic nomogram for human epidermal growth factor receptor 2 negative early young breast cancer in women.
Journal: Discover oncology
Published: March 31, 2026
Glucose‑driven TRIB3 enhances the tumorigenic potential of colon cancer via the PI3K/AKT pathway.
Journal: Molecular medicine reports
Published: August 06, 2025
Glecirasib with or without cetuximab in previously treated locally advanced or metastatic colorectal cancer with KRASG12C mutation (JAB-21822-1002 and JAB-21822-1007): two open-label, non-randomised phase 1/2 trials.
Journal: The lancet. Gastroenterology & hepatology
Published: April 03, 2025
Hypoxic stimulation of DCLK1 transcription and alternative-promoter switching fuels tumor malignancy in clear cell renal cell carcinoma.
Journal: Cell death & disease
Published: November 25, 2024
Camrelizumab plus carboplatin and pemetrexed as first-line therapy for advanced non-squamous non-small-cell lung cancer: 5-year outcomes of the CameL randomized phase 3 study.
Journal: Journal for immunotherapy of cancer
Published: October 10, 2024
Correction: Risk Factors of Distant Metastatic Parathyroid Carcinoma and Insights into Therapeutic Perspectives.
Journal: Annals of surgical oncology
Published: July 01, 2024
Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial.
Journal: Nature medicine
Published: June 11, 2024
ASO Author Reflections: Distant Metastatic Parathyroid Carcinoma: Risk Factors, Patterns, and Outcomes.
Journal: Annals of surgical oncology
Published: June 10, 2024
Targeting the PI3K/AKT/mTOR pathway offer a promising therapeutic strategy for cholangiocarcinoma patients with high doublecortin-like kinase 1 expression.
Journal: Journal of cancer research and clinical oncology
Published: April 23, 2024
Risk Factors of Distant Metastatic Parathyroid Carcinoma and Insights into Therapeutic Perspectives.
Risk Factors of Distant Metastatic Parathyroid Carcinoma and Insights into Therapeutic Perspectives.
Journal: Annals of surgical oncology
Published: March 28, 2024
GGT5: a potential immunotherapy response inhibitor in gastric cancer by modulating GSH metabolism and sustaining memory CD8+ T cell infiltration.
Journal: Cancer immunology, immunotherapy : CII
Published: November 03, 2023
Last Updated: 09/26/2026